Colgate-Palmolive Company (CL) Stock Analysis
Breakout setup
Consumer Defensive · Household & Personal Products
Sell if holding. Analyst target reached at $89.92 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 16.4): -1.5.
Colgate-Palmolive manufactures and markets consumer products across Oral, Personal & Home Care and Pet Nutrition segments, with products sold in over 200 countries and approximately two-thirds of Net sales outside the United States. Fiscal 2025 net sales were approximately flat... Read more
Sell if holding. Analyst target reached at $89.92 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 16.4): -1.5. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Score 5.5/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 74d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: conservative.
Recent Developments — Colgate-Palmolive Company
Material events (past 30 days)
- May 1, 2026 MEDIUM Item 2.05: Colgate-Palmolive disclosed costs associated with its Strategic Growth and Productivity Program, a three-year restructuring initiative approved by the Board on July 31, 2025 to align organizational structure with 2030 strategy.
Latest news
- Ahead of Colgate-Palmolive’s (CL) Q1 Results, Here’s What Technical Indicators Are Suggesting - TipRanks — TipRanks neutral
- Wealthfront Advisers LLC Increases Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat — MarketBeat neutral
- Colgate-Palmolive: A Mixed Bag in Consumer Goods Investing - The Globe and Mail — The Globe and Mail neutral
- Amphenol Corp. Cl A stock underperforms Tuesday when compared to competitors - MarketWatch — MarketWatch negative
- Flossbach Von Storch SE Raises Stock Position in Colgate-Palmolive Company $CL - MarketBeat — MarketBeat positive
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- LOWCustomerWalmart11%10-K Item 1: 'Our sales to Walmart, Inc. and its affiliates represented approximately 11% of our Net sales in 2025'
Material Events(8-K, last 90d)
- 2026-05-01Item 2.05MEDIUMColgate-Palmolive disclosed costs associated with its Strategic Growth and Productivity Program, a three-year restructuring initiative approved by the Board on July 31, 2025 to align organizational structure with 2030 strategy.SEC filing →
- 2026-04-09Item 5.02MEDIUMJennifer M. Daniels (CLO since 2014) to retire in 2026. Betsy Fishbone elected as successor CLO & Secretary effective June 1, 2026. Daniels appointed Vice Chair for transition. Clean handoff with named successor.SEC filing →
- 2026-03-12Item 5.02LOWChristopher S. Boerner, Ph.D. (CEO of Bristol-Myers Squibb) elected to Colgate-Palmolive Board of Directors effective March 15, 2026.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $89.92 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 16.4): -1.5. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Prior stop was $85.72. Score 5.5/10, moderate confidence.
Take-profit target: $88.91 (-1.1% upside). Prior stop was $85.72. Stop-loss: $85.72.
Analyst target reached - limited upside remaining; Leverage penalty (D/E 16.4): -1.5; Weak growth.
Colgate-Palmolive Company trades at a P/E of 34.2 (forward 21.8). TrendMatrix value score: 4.9/10. Verdict: Sell.
30 analysts cover CL with a consensus score of 3.8/5. Average price target: $96.
What does Colgate-Palmolive Company do?Colgate-Palmolive manufactures and markets consumer products across Oral, Personal & Home Care and Pet Nutrition...
Colgate-Palmolive manufactures and markets consumer products across Oral, Personal & Home Care and Pet Nutrition segments, with products sold in over 200 countries and approximately two-thirds of Net sales outside the United States. Fiscal 2025 net sales were approximately flat versus prior year, with strength in oral care offset by macroeconomic headwinds.